Literature DB >> 10701144

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

C Gasche1, J Scholmerich, J Brynskov, G D'Haens, S B Hanauer, E J Irvine, D P Jewell, D Rachmilewitz, D B Sachar, W J Sandborn, L R Sutherland.   

Abstract

Crohn's disease is a heterogeneous entity. Previous attempts of classification have been based primarily on anatomic location and behavior of disease. However, no uniform definition of patient subgroups has yet achieved broad acceptance. The aim of this international Working Party was to develop a simple classification of Crohn's disease based on objective variables. Eight outcome-related variables relevant to Crohn's disease were identified and stepwise evaluated in 413 consecutive cases, a database survey, and by clinical considerations. Allocation of variables was conducted with well-defined Crohn's disease populations from Europe and North America. Cross-table analyses were performed by chi-square testing. Three variables were finally elected: Age at Diagnosis [below 40 years (A1), equal to or above 40 years (A2)], Location [terminal ileum (L1), colon (L2), ileocolon (L3), upper gastrointestinal (L4)], and Behavior [nonstricturing nonpenetrating (B1), stricturing (B2), penetrating (B3)]. The allocation of patients to these 24 subgroups proved feasible and resulted in specific disease clusters. Cross-table analyses revealed associations between Age at Diagnosis and Location, and between Behavior and Location (all p < 0.001). The Vienna classification of Crohn's disease provides distinct definitions to categorize Crohn's patients into 24 subgroups. Operational guidelines should be used for the characterization of patients in clinical trials as well as for correlation of particular phenotypes with putative biologic markers or environmental factors.

Entities:  

Mesh:

Year:  2000        PMID: 10701144     DOI: 10.1097/00054725-200002000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  266 in total

Review 1.  Antibiotics in Crohn's disease.

Authors:  J F Colombel; A Cortot; H J van Kruiningen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

3.  Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine.

Authors:  B A Kaskas; E Louis; U Hindorf; E Schaeffeler; J Deflandre; F Graepler; K Schmiegelow; M Gregor; U M Zanger; M Eichelbaum; M Schwab
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.

Authors:  Zhaoxia Zhang; Chen Li; Xinmei Zhao; Chaolan Lv; Qiong He; Shan Lei; Yandong Guo; Fachao Zhi
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

5.  Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes.

Authors:  Marla C. Dubinsky; Phillip P. Fleshner
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

6.  Histopathological parameters as predictors for the course of Crohn's disease.

Authors:  Frauke Bataille; Frank Klebl; Petra Rümmele; Rainer H Straub; Peter Wild; Jürgen Schölmerich; Ferdinand Hofstädter
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

7.  Behaviour of Crohn's disease according to the Vienna classification.

Authors:  D B Sachar
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

9.  Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.

Authors:  C Alexakis; J P Caruelle; A Sezeur; J Cosnes; J P Gendre; H Mosnier; L Beaugerie; D Gallot; M Malafosse; D Barritault; P Kern
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.